Expanded-Access Use of Elamipretide in a Patient with Membrane
Protein-Associated Neurodegeneration
- Jorge Patino,
- Anna Haertling Clearman,
- Lindsey Miller,
- Mary Kay Koenig
Anna Haertling Clearman
University of Texas McGovern Medical School
Author ProfileLindsey Miller
University of Texas McGovern Medical School
Author ProfileMary Kay Koenig
University of Texas McGovern Medical School
Author Profile18 Apr 2024Submitted to Clinical Case Reports 22 Apr 2024Submission Checks Completed
22 Apr 2024Assigned to Editor
28 Apr 2024Reviewer(s) Assigned
26 May 2024Editorial Decision: Revise Minor
03 Jun 20241st Revision Received
12 Jun 2024Review(s) Completed, Editorial Evaluation Pending